![](/img/cover-not-exists.png)
The Cost-Effectiveness of Initial Treatment of Multiple Myeloma in the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide Maintenance Treatment
Garrison, L. P., Wang, S.-T., Huang, H., Ba-Mancini, A., Shi, H., Chen, K., Korves, C., Dhawan, R., Cakana, A., van de Velde, H., Corzo, D., Duh, M. S.Volume:
18
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2011-0380
Date:
January, 2013
File:
PDF, 179 KB
english, 2013